AI Article Synopsis
- This study looked at how Medicare payments for breast cancer treatments and reconstructive surgeries changed from 2010 to 2021.
- It found that, on average, Medicare reimbursement decreased by 15% overall, with breast oncology payments dropping by 11% and reconstructive procedure payments by 16%.
- The authors suggest that surgeons in these fields should push for better reimbursement rates that accurately reflect their practice costs.
Article Abstract
This study evaluated trends in Medicare reimbursement for commonly performed breast oncologic and reconstructive procedures. Average national relative value units (RVUs) for physician-based work, facilities, and malpractice were collected along with the corresponding conversion factors for each year. From 2010 to 2021, there was an overall average decrease of 15% in Medicare reimbursement for both breast oncology (-11%) and reconstructive procedures (-16%). Based on these findings, breast and reconstructive surgeons should advocate for reimbursement that better reflects the costs of their practice.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bjps.2024.04.064 | DOI Listing |
Publication Analysis
Top Keywords
medicare reimbursement
12
trends medicare
8
reimbursement breast
8
reconstructive procedures
8
reimbursement
4
breast
4
breast cancer
4
reconstructive
4
cancer reconstructive
4
reconstructive surgery
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!